Sahajanand Medical Technologies Limited (SMT) is an Indian medical-device manufacturer specializing in minimally invasive cardiovascular and vascular intervention products. Its portfolio includes coronary stents and balloon catheters used in procedures to treat narrowed or obstructed blood vessels. The company also develops structural heart devices, including transcatheter aortic valve implantation (TAVI) products and occluders used to address certain structural heart conditions. Additional products include devices for peripheral vascular interventions and renal applications. SMT serves hospitals, cardiac centres, interventional cardiologists, distributors and healthcare providers in India and international markets. Its business depends on medical-device research and development, product engineering, manufacturing quality, regulatory approvals and clinical adoption. The company aims to provide interventional medical technologies across a range of cardiovascular treatment needs. Revenue is generated primarily from the sale of medical devices to healthcare providers and through distribution partners.
Loading chart…
This company hasn't held an earnings call in the last six months, so there's no recent commentary from management. Our deep dives are built on what management actually said, so we haven't prepared one.